Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567281 · ClinicalTrials.gov registry record · NA
Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Original Study
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00567281: Completed NA study, sponsored by Yale University.
NCT00567281 is a NA study that has completed, run by Yale University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00567281, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This trial is designed to determine if administering repetitive transcranial magnetic stimulation (rTMS) simultaneously to two sites in the temporal lobes, one on the left and one on the right, produces greater improvements in "voices" and other symptoms of schizophrenia compared to rTMS given to just one site in the temporal lobes.
Interventions
- DEVICE Magstim Rapid 2 system triggering Magstim Super Rapid system
- DEVICE Magstim Rapid-2 system triggering Magstim Super Rapid system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-10 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT00567281 record still lists
NCT00567281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Magstim Rapid 2 system triggering Magstim Super Rapid system is the first listed.
NCT00567281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00567281 about?
NCT00567281 is a clinical study titled "Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Original Study". This trial is designed to determine if administering repetitive transcranial magnetic stimulation (rTMS) simultaneously to two sites in the temporal lobes, one on the left and one on the right, produces greater improvements in "voices" and other symptoms of schizophrenia compared to rTMS given to ju...
What is the current status of trial NCT00567281?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-10. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00567281?
The interventions under investigation include: Magstim Rapid 2 system triggering Magstim Super Rapid system (DEVICE), Magstim Rapid-2 system triggering Magstim Super Rapid system (DEVICE).
Who is sponsoring clinical trial NCT00567281?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00567281's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia